JPJinjae Park

Jinjae Park

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jinjae Park has a total of 16 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Divergent Synthesis of (+)-Kuhistanicaol G and (+)-Ferutinin through the Common Intermediate Jaeschkeanadiol

    by Jinjae Park, Yoojin Lim, Yiquan Zhao, Eric C. Wang, Iljin Shin, Jiyong Hong

    Motivated by the potent anticancer activity of kuhistanicaol G and ferutinin against the pancreatic cancer cell line PANC-1, we report the total syntheses of (+)-kuhistanicaol G and (+)-ferutinin. Our divergent synthetic strategy proceeds through the common intermediate jaeschkeanadiol and features several key transformations, including tandem radical addition/allylation, chelation-controlled nucleophilic addition, and Chugaev elimination. This work establishes a robust platform for the synthesis of structurally diverse analogues of (+)-kuhistanicaol G and (+)-ferutinin, as well as mechanistic chemical probes, thereby facilitating the future development of natural product-derived therapeutics for pancreatic cancer.

  • Development of a Protocol for Synthesis of Nitrocinnamonitriles from Nitrotoluenes

    by Tae Won Kim, Jinjae Park, Cheol-Hong Cheon

    A novel protocol for the synthesis of 2- and 4-nitrocinnamonitriles from the corresponding nitrotoluene derivatives has been developed. Condensation of 2- or 4-nitrotoluene derivatives with N,N-dimethylformamide dimethyl acetal (DMF·DMA) afforded the corresponding (2- or 4-nitrophenyl)acetaldehyde enamines. Subsequent Strecker-type hydrocyanation across the enamine moiety, followed by Cope elimination of the N,N-dimethylamino group, furnished the desired nitrocinnamonitriles. This method was broadly applicable to ortho- and para-nitrotoluene derivatives and provided a variety of structurally diverse nitrocinnamonitriles in good to high yields. Notably, the protocol exhibited exclusive site selectivity, functionalizing only the benzylic position ortho or para to the nitro substituent on the nitrotoluene scaffold. Furthermore, it was compatible with polysubstituted aromatic rings and could be readily extended to a broad range of heteroaromatic systems.

  • Synthesis of belumosudil

    by Sangjun Park, Jinjae Park, Tae Lyn Kim, Cheol‐Hong Cheon

    We developed a novel synthetic route to belumosudil featuring an oxidative cyclization of anthranilamide with meta ‐substituted benzaldehyde as the key step for constructing the quinazolinone scaffold. Alkylation of 3‐hydroxybenzaldehyde with 2‐chloroacetamide furnished a benzaldehyde derivative bearing the desired meta ‐substituent. Subsequent metal‐free aerobic oxidative cyclization of anthranilamide and the aldehyde in DMSO afforded the desired quinazolinone. Treatment with POCl 3 converted the quinazolinone intermediate into the corresponding quinazolinyl chloride, which was then coupled with 5‐aminoindazole to complete the synthesis of belumosudil.


  • Asymmetric Total Synthesis of Daucane-Type Sesquiterpenoids (+)-Ferutinin and (+)-Kuhistanicaol G

    by Yiquan Zhao, Eric C. Wang, Jinjae Park, Iljin Shin, Hyoungsu Kim, Jiyong Hong

    Given the poor outcomes associated with current pancreatic cancer therapies, the "antiausterity" activity of ferutinin and kuhistanicaol G is particularly encouraging. The asymmetric syntheses of (+)-ferutinin and (+)-kuhistanicaol G are achieved through a sequence involving tandem radical addition/allylation, chelation-controlled nucleophilic addition, and Chugaev elimination. This synthetic strategy enables the efficient construction of appropriately functionalized 5,7-fused daucane skeletons. Our work paves the way for the development of new pancreatic cancer therapeutics and provides access to chemical probes for elucidating mechanisms of action.


  • Development of Two Synthetic Routes to 4‐(N‐Boc‐N‐methylaminomethyl)benzaldehyde: A Versatile Starting Material in Pharmaceutical Synthesis

    by Jinjae Park, Myunghoon Jeong, Shirun Li, Ju‐Ahn Seo, Yong Ho Lee, Cheol‐Hong Cheon

    Two novel synthetic routes to 4‐(N‐Boc‐N‐methylaminomethyl)benzaldehyde, an important pharmaceutical starting material, were developed using terephthaloyl chloride and terephthalaldehyde. In the first approach, terephthaloyl chloride was converted to an ester amide. The treatment of the ester amide with LiAlH4 followed by protection of the resulting amine with tert‐butoxycarbonyl anhydride yielded the corresponding benzyl alcohol. The benzyl alcohol was oxidized to the aldehyde completing the first‐generation synthesis. The second approach utilized a one‐step protocol mono‐selective reductive amination of terephthalaldehyde with N‐Boc‐methylamine using chlorodimethylsilane. Both methods were scalable to 50 mmol and provided the desired aldehyde in a synthetically useful yield, demonstrating their practicality.


  • Development of Synthetic Route for 3‐Amino‐5‐halo‐2‐iodobenzoates: Versatile Starting Materials in Pharmaceuticals Synthesis

    by Jinjae Park, Ju‐Ahn Seo, Cheol‐Hong Cheon

    A novel synthetic route to 3‐amino‐5‐halo‐2‐iodobenzoates, which are used as versatile starting materials in the synthesis of pharmaceuticals, was developed using commercially available 2‐aminobenzoates bearing a suitable halogen atom at the C5 position as the starting material. Synthesis was initiated with the introduction of a nitro group at the C3 position of the appropriate 2‐aminobenzoates, forming 2‐amino‐3‐nitrobenzoates with a C5‐halogen atom. The subsequent conversion of the C2‐amino group to an iodide yielded 5‐halo‐2‐iodo‐3‐nitrobenzoates, which were further converted into the desired 3‐amino‐5‐halo‐2‐iodobenzoates by reducing the C3‐nitro group to an amino group. It is worth noting that this transformation can be conducted on a 50 mmol scale, and the desired benzoate compounds were obtained in good yield, demonstrating the practical applicability of this protocol.


  • Synthesis of a Pinacol Boronate Precursor for [18F]Rucaparib Radiosynthesis

    by Ju‐Ahn Seo, Jinjae Park, Cheol‐Hong Cheon

    A novel synthetic approach toward pinacol boronate used as a precursor in the recent radiosynthesis of [18F]rucaparib is described in this study. The Heck reaction of an ortho‐iodoaniline derivative bearing a chloride group at the meta‐position with acrylonitrile produced the desired (E)‐2‐aminocinnamonitrile derivative. The subsequent cyanide‐catalyzed imino‐Stetter reaction of aldimine derived from the obtained 2‐aminocinnamonitrile and aldehyde afforded the required trisubstituted indole‐3‐acetonitrile. The reduction of the nitrile group with cobalt boride followed by the construction of an azepinone scaffold generated indoloazepinone bearing a chloride substituent at the C6‐position of the indole scaffold. The Suzuki–Miyaura borylation of the chloride substituent produced pinacol boronate previously used in the synthesis of [18F]rucaparib. Detailed outcomes of different approaches using different 2‐aminocinnamonitriles were discussed as well.


  • Synthesis of 2-(2-nitrophenyl)indoline-3-acetic acid derivatives via base-catalyzed cyclization of N-(2-nitrobenzyl)-2-aminocinnamic acid derivatives

    by Ju Hyeon Park, Jinjae Park, Cheol-Hong Cheon

    The first synthetic protocol for the synthesis of cis-2-(2-nitrophenyl)indoline-3-acetic acid derivatives was developed via base-catalyzed cyclization of N-(2-nitrobenzyl)-2-aminocinnamic acid derivatives.


  • Open Access

    A cyanide-catalyzed imino-Stetter reaction enables the concise total syntheses of rucaparib

    by Jinjae Park, Cheol-Hong Cheon

    Two routes toward the synthesis of rucaparib, an FDA-approved drug used for the treatment of ovarian and prostate cancers, have been developed from commercially available starting materials utilizing the cyanide-catalyzed imino-Stetter reaction as the key step for the construction of the indole motif bearing all the desired substituents in their correct positions. In the first-generation synthesis, meta-fluorobenzoate, the starting material currently used in the process chemistry route of rucaparib, was converted into 4,6-disubstituted 2-aminocinnamic acid derivatives (ester or amide). The cyanide-catalyzed imino-Stetter reaction of aldimines derived from the resulting 2-aminocinnamic acid derivatives and a commercially available aldehyde afforded the desired indole-3-acetic acid derivatives. The final azepinone formation completed the total synthesis of rucaparib in 27% overall yield. To resolve the issues raised in the first-generation synthesis, we further developed a second-generation synthesis of rucaparib. The Heck reaction of a commercially available ortho-iodoaniline derivative with acrylonitrile provided 4,6-disubstituted 2-aminocinnamonitrile, which was subjected to the imino-Stetter reaction with the same aldehyde to provide the desired indole-3-acetonitrile product. Subsequent construction of the azepinone scaffold completed the total synthesis of rucaparib in 59% overall yield over three separation operations. The synthetic strategy reported herein can provide a highly practical route to access rucaparib from commercially available starting materials (5.2% overall yield in the current process chemistry route vs. 59% overall yield in the second-generation synthesis).